Although established more than 30 years ago, the field of flow cytometry continues to grow and advance. It remains an indispensable tool for clinicians and researchers. The “Northwest Regional ...
Flow cytometry is a strong analytical method that is utilized to determine, measure, and examine cells and particles in a heterogeneous mixture. The standard instrument comprises three primary ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This ...
A research team from George R Brown School of Engineering and Computing (Rice University; TX, USA), led by Peter Lillehoj and Kevin Mchugh, have developed an innovative AI-enabled microfluidic ...
After five decades of use, flow cytometry is entrenched in biomedical science. Besides enabling the quick processing of cells in suspension, flow cytometry provides quantitative results across ...
Cytek Biosciences, Inc. has announced the launch of the Cytek Aurora™ Evo system, an advanced full spectrum flow cytometer designed to enhance cell analysis capabilities. Building on the success of ...
Setting up reliable controls is one of the priorities that any scientist should be concerned with when engaging in scientific research and experimentation. Without controls, it is nearly impossible to ...
FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. ...
Flow cytometry remains a critical technology for the high-throughput analysis of single cells in complex populations. Attention to good analysis practices is more important than ever due to the recent ...
Flow cytometry is a technique that is used to detect and measure the chemical and physical characteristics of a cell population. This technique, which was first used in the 1950s, can also be used to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results